Showing results (121-130 of 229) with videos related to
Sort By:
Pageof 23
Journal of Internal Medicine|December 11, 2002
Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well-preserved liver functionS Ormarsdóttir, O Ljunggren, H Mallmin, et al.Cancer Detection and Prevention|July 23, 1998
DNA repair enhancement by a combined supplement of carotenoids, nicotinamide, and zincY Sheng, R W Pero, A R Olsson, et al.Diabetologia|July 13, 2006
Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasisB Ohlsson, O Melander, O Thorsson, et al.Hepato-Gastroenterology|August 1, 1980
Natural protease inhibitors to fibrinolysis in liver diseasesR Arnman, E Gyzander, U Hedner, et al.Diabetologia|May 7, 2005
Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet graftsC Kampf, T Lau, R Olsson, et al.European Journal of Pharmacology|November 20, 1990
Effects of selective dopamine D1 and D2 receptor agonists on the rate of GABA synthesis in mouse brainA F Steulet, R Bernasconi, T Leonhardt, et al.Alimentary Pharmacology & Therapeutics|October 4, 2006
Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinicM B De Valle, V Av Klinteberg, N Alem, et al.Anesthesiology|February 7, 2001
The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracuriumE Sundman, H Witt, R Olsson, et al.Journal of Hepatology|May 1, 1992
Liver damage from flucloxacillin, cloxacillin and dicloxacillinR Olsson, B E Wiholm, C Sand, et al.Clinical Pharmacokinetics|September 1, 1981
Pharmacokinetics of metoprolol in patients with hepatic cirrhosisC G Regårdh, L Jordö, M Ervik, et al.Pageof 23